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Background. Bicuspid aortic valve (BAV) is one of the most common congenital heart disease (0.9%–2%) and is frequently found in
the athletes and in the general population. BAV can lead to aortic valve dysfunction and to a progressive aortic dilatation. Trained
BAV athletes exhibit a progressive enlargement of the left ventricle (LV) compared to athletes with normal aortic valve morphology.
The present study investigates the possible relationship between different aortic valve morphology and LV dimensions. Methods.
In the period from 2000 to 2011, we investigated a total of 292 BAV subjects, divided into three different groups (210 athletes, 59
sedentaries, and 23 ex-athletes). A 2D echocardiogram exam to classify BAV morphology and measure the standard LV systo-
diastolic parameters was performed. The study was conducted as a 5-year follow-up echocardiographic longitudinal and as cross-
sectional study. Results. Typical BAV was more frequent in all three groups (68% athletes, 67% sedentaries, and 63% ex-athletes)
than atypical. In BAV athletes, the typical form was found in 51% (107/210) of soccer players, 10% (21/210) of basketball players,
10% track and field athletics (20/210), 8% (17/210) of cyclists, 6% (13/210) swimmers, and 15% (32/210) of rugby players and others
sport. Despite a progressive enlargement of the LV (𝑃 < 0.001) observed during the follow-up study, no statistical differences
of the LV morphology and function were evident among the diverse BAV patterns either in sedentary subjects or in athletes.
Conclusion. In a large population of trained BAV athletes, with different prevalence of typical and atypical BAV type, there is a
progressive nonstatistically significant enlargement of the LV. In any case, the dimensions of the LV remained within normal range.
Themetabolic requirements of the diverse sport examined in the present investigations do not seem to produce any negative impact
in BAV athletes
1. Introduction
Bicuspid aortic valve (BAV) is one of the most common
congenital heart disease (0.9%–2%) and is frequently found
in athletes and in the general population [1]. BAV can lead
to aortic stenosis, aortic regurgitation, infective endocarditis,
and progressive aortic dilatation [2, 3]. Different spatial
orientations of the BAV have been identified [4]. The most
frequent BAV subtypes are those with fusion of the right
and noncoronary leaflets (R-NC) and those with fusion of
right and left coronary leaflets (R-L) [5]. Patients with a BAV
with R-NC fusion have a higher risk of aortic stenosis and
regurgitation. In addition, the elastic properties of the aorta
deteriorate, and the dimensions of the aorta tend to increase
[6]. Patients with R-L BAV exhibit a more severe degree of
aortic wall degeneration than patients with R-NCBAV, and in
addition R-L BAV is associated with coarctation of the aorta
(CoA) [7]. Studies in children and adolescents have proven
that R-NC BAV subjects show a more rapid progression of
aortic valve stenosis and regurgitation [8].These data suggest
that the etiological factors that determine the formation of R-
NC and R-L BAVs can also be involved in the occurrence and
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progression of pathologies associatedwith each BAV subtype.
More recently, in addition to the progressive enlargement of
the ascending aorta, a progressive increase of the left ventricle
(LV) dimensions has been also demonstrated [9], especially
in BAV athletes with mild aortic valve insufficiency. In BAV
athletes, the LV dimensions remain within the normal range,
although such dimensions are higher compared to subjects
with normal tricuspid aortic valve. Currently, it remains
unknown whether the different BAV subtypes are associated
to different patterns of changes in LVdimensions.Thepresent
study aims to verify in a wide population of BAV subjects
the prevalence of the different morphologies of bicuspid
aortic valve subtypes and the possible association of these
subtypes with amore evident enlargement of the LV chamber
dimensions.
2. Materials and Methods
2.1. Subjects Studied. In the period from 1 January 2000 to
31 December 2011, 292 consecutive subjects with BAV were
evaluated at the Sports Medicine and Exercise Centre of the
University of Florence.The group included active athletes, ex-
athletes, and sedentary subjects.
The active athletes group was composed of subjects
who undertook competitive sport, trained regularly, and
underwent yearly evaluation at the Sports Medicine and
Exercise Centre to obtain eligibility to practice sports. The
ex-athletes were subjects who spontaneously decided to stop
their training and sport activity for nonhealth related reasons.
Sedentary subjects had never practised regular sport activity.
The formula weight (kg)/height in (m2) was applied to calcu-
late the body mass index (BMI). In all groups, the presence
of BAV was investigated by a 2D echocardiographic exam to
estimate the prevalence of the different BAV morphologies.
Only in the athletes was the possible LV morphology and
function modifications associated to a diverse BAV mor-
phology studied. Among the athletes, only the subjects with
a complete 5-year followup were investigated. In the other
two groups, the presence of BAV and its morphology was
assessed.
2.2. Echocardiographic Study. All the subjects were investi-
gated by history taking, general physical examination, and
2D echocardiographic exam at rest. The echocardiogram
was performed by cardiologists sonographers experts using
the echocardiograph My Lab 50 (Esaote, Italy) equipped
with a 2.5MHz transthoracic echocardiographic probe.
According to the ACC/AHA guidelines [10], the echocar-
diographic measurements of the left ventricle (LV) cham-
ber were obtained from the parasternal long-axis view.
They included LV end-systolic and end-diastolic diameters
(LVEDd, LVESd), interventricular septum (IVS), posterior
wall thickness (PW), and the ejection fraction (EF %), cal-
culated according to the formula (LVEDd-LVESd/LVEDd),
for which volumes are substituted by diameters. By Doppler
analysis, the diastolic variables weremeasured in the presence
of a stable RR interval and in three different but sequential
measurements from the four chamber view. They consisted
in transmitral flow of E wave and A wave peak velocities,
isovolumetric relaxation and deceleration times, and E/A
ratio. The degree of severity of the insufficiency, described
as the extent of the regurgitant jet on a 0 to 4+ scale, was
assessed using the colour-flow mapping method from the
four-chamber view, according to the ACC/AHA guidelines
[11]. The index of left ventricular mass (LVMI) and left
ventricular hypertrophy (LVH) was calculated according to
the equation by Devereux [12]. Aortic valve morphology was
examined in the parasternal long- and short-axis views. The
diagnosis of BAV was confirmed when two cusps and two
commissures were clearly identified in systole and diastole
in the short-axis view. The aortic dimensions were measured
in 2-dimensional parasternal long axis views at the end of
diastole in the views at four levels: aortic annulus (Aoan),
Valsalva sinuses (Aosv), sinotubular junction (Aostj), and
proximal ascending aorta (PAA), measured 1 cm from the stj
[13]. Every BAV type was immediately classified according to
the presence or absence of a fibrous raphe of one of the two
cusps.
In the phenotype “with raphe” three variants of BAV have
been identified: the first and most common is characterized
by fusion of right and left coronary cusp (R-L), the second
presents right and noncoronary fusion (R-NC), and the third,
less common variant, presents left and noncoronary fusion
(L-NC).
In the phenotype “no raphe,” only two cusps with free
margin and commissures are present. The orientation of the
commissures and the free margin [14] allows to distinguish
anteroposterior (AP) and a lateral (LA) variants.
The evaluation of the aorta was completed measuring the
ascending aortic tract at four different levels (aortic annulus
(Aoan), sinuses of Valsalva (Aosv), joint sino-tubular (Aostj),
proximal ascending aorta (PAA), measured at 1 cm from the
joint sino-tubular).
The presence of aortic stenosis (AS) was assessed over the
window apical 4-chamber with continuous-wave Doppler.
The flow velocity of transvalvular aortic of 2.5m/sec (cor-
responding to the maximum gradient of 25mmHg) was
compatible with the presence of stenosis.
Echocardiography also included the evaluation of other
possible anatomical or hemodynamic abnormalities, such as
the presence of other valvular regurgitation, mitral and/or
tricuspid, the calculation of the pulmonary pressure, the
presence of CoA, interventricular or interatrial septal defects,
or a patent foramen ovale.
3. Statistical Analysis
The results are reported as mean ± standard deviation.
The differences in the values of the LV among athletes
with different morphologies of BAV were evaluated with
multivariate analysis using ANOVA. 𝑃 values < 0.05 were
considered statistically significant.
4. Results
4.1. General Data. The BAV population studied (Figure 1)
was composed of 292 subjects, including 210 athletes (72%
of the population), 23 ex-athletes (8%), and 59 sedentary
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Figure 1: Composition of the whole population investigated (ath-
letes, ex-athletes, and sedentaries).
subjects (20%). The athletes and the sedentary subjects were
followed at yearly intervals with echocardiography for at
least 5 years. Within all three groups, the morphology of
BAV “with raphe” has been more represented than the BAV
“without raphe.” BAV “with raphe” was found, respectively,
in the 68% (143) of athletes, 65% (16) of the ex-athletes, and
63% (37) of the sedentary subjects. The presence of other
associated minor cardiac abnormalities such as mitral valve
prolapse (MVP) or patent foramen ovalis (PFO) in all three
populations was very low. Only 9/56 of the sedentary subjects
however showed a progressive valve dysfunction or dilatation
of the ascending aorta and underwent cardiac surgery.
4.2. Athletes Group. The BAV athletes were from different
types of sports: 51% football, 10% basketball, 10% track and
field athletics, 8% cycling, 6% swimming, and the remaining
15% practiced other sports such as rugby, fencing, martial
arts, volleyball, tennis, horse-riding, triathlon, diving, danc-
ing, and boxing. All the athletes were competitive athletes and
trained at least three times a week for 10 months a year, and,
in the competitive season, competed at least once a week.The
most common variant found at echocardiography was the
BAV “with raphe” with the R-L morphology subtype. It was
the most represented in both athletes (70%) and ex-athletes
(73%). The R-NC type had a prevalence of 29% in athletes
and 27% in the ex-athletes. In the variant bicuspid aortic
valve “without raphe,” the AP type has a prevalence of 87%
in athletes and 93% in the ex-athletes. The LA type had a
prevalence of 13% in athletes and 7% in the ex-athletes. None
of the athletes underwent surgery during the study period.
At colour Doppler exam, the most prevalent aortic valve
dysfunction found in athletes was valve insufficiency. It was
present in 84% of the whole athletes BAV group (athletes
and ex-athletes) without raphe, and in 80% of the BAV
athletes with raphe. The degree of aortic valve insufficiency
was estimated by the colour Doppler analysis and was always
mild. On the contrary, aortic valve stenosis was found in
the 3% of the group “without raphe,” and in the 0.7% of
the group of BAV athletes with raphe. In the rest, the aortic
valve was functioning normally (13% in the subjects without
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13% normal valve
4.5% mitral prolapse
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Figure 2: Presence of BAV morphologies and associated cardiac
patterns in the whole athletes BAV group.
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Figure 3: Presence of the BAV morphologies in sedentaries. AP:
anteroposterior; LA: lateral; RL: right left; RNC: right non coronary;
LNC: left noncoronary.
raphe, and 19.3% in the group with raphe). In the same group,
otherminor congenital cardiac abnormalitieswere found. For
example, amitral valve prolapse (MVP)was found in the 3.5%
of the BAV group with raphe, and in the 4.5% of the no raphe
group. A patent foramen ovalis (PFO) was found in 0.7% of
the BAV group with raphe. A ventricle septal defect (VSD)
was found only in the group of BAV athletes without raphe, as
well as the coartaction of aorta in the 1.5% of the same subtype
of the athletes group (Figure 2).
4.3. Sedentary Group. The sedentary group was composed
of 59 subjects, of which 41 had a complete 5-year followup
and whose prevalence of the BAV morphology is shown in
Figure 3.
The behaviour of the 4 diameters of the aortic tract,
with respect to the diverse morphological pattern, showed in
sedentaries dimensions higher than the normal subjects with
a major enlargement of the BAV LNC variant (Table 1).
Themost common BAVmorphology was R-L with raphe,
in 62% of them.TheR-NCwas found in 35%.The raphe L-NC
type had a prevalence of 1%. In the BAVmorphology “without
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Table 1: Dimensions of the aortic tract in BAV sedentaries with diverse morphological patterns.
Sedentary Aoan (mm) Aosv (mm) Aostj (mm) PAA (mm)
BAV AP 34.66 ± 4.75 37.46 ± 4.91 37.53 ± 5.51 36.6 ± 6.28
BAV LA 33.6 ± 4.36 36.73 ± 4.76 36.6 ± 6.49 35.33 ± 6.78
BAV RL 38.22 ± 6.63 42.22 ± 6.40 40.55 ± 7.54 41.55 ± 7.49
BAV RNC 33.26 ± 4.86 36.63 ± 4.95 36.47 ± 4.89 36.21 ± 5.12
BAV LNC 38 45 43 43
BAV: bicuspid aortic valve; AP: anteroposterior; LA: lateral; RL: right left; RNC: right noncoronary; LNC: left noncoronary.
Table 2: Echocardiographic features of the athletes with different types of bicuspid aortic valve.
R-L = 101 R-NC = 41 L-NC = 2 A-P = 59 L-A = 8 P
Age 29.11 ± 12.12 29.36 ± 12.03 28.83 ± 12.37 29.24 ± 12.05 28.97 ± 12.00 NS
EF (%) 60 ± 18 59 ± 18 62 ± 10 59 ± 18 60 ± 18 NS
BSA in (m2) 1.80 ± 0.2 1.81 ± 0.2 1.79 ± 0.29 1.81 ± 0.2 1.81 ± 0.2 NS
IVS (mm) 9.42 ± 1.5 9.47 ± 1.4 9.34 ± 1.32 9.46 ± 1.4 9.50 ± 1.3 NS
PW (mm) 9.18 ± 1.5 9.23 ± 1.3 9.10 ± 1.32 9.23 ± 1.3 9.27 ± 1.2 NS
LVEDd (mm) 50.12 ± 7.4 50.42 ± 6.6 49.97 ± 4.44 50.39 ± 6.6 50.61 ± 5.5 NS
LVESd (mm) 31.52 ± 5.1 31.70 ± 4.7 31.88 ± 2.91 31.71 ± 4.7 31.86 ± 4.2 NS
CMI in (g/m2) 111.66 ± 23.2 111.83 ± 23.4 110.98 ± 19.9 111.58 ± 23.3 111.04 ± 21.9 NS
Aoan (mm) 31.15 ± 4.2 31.26 ± 4.2 30.52 ± 5.00 31.19 ± 4.2 31.10 ± 4.2 NS
Aosv (mm) 33.83 ± 4.6 33.96 ± 4.5 33.26 ± 6.08 33.90 ± 4.5 33.85 ± 4.5 NS
Aostj (mm) 33.00 ± 4.7 33.10 ± 4.6 32.73 ± 6.01 33.03 ± 4.6 33.96 ± 4.7 NS
PAA (mm) 32.30 ± 4.92 32.45 ± 4.8 31.36 ± 6.58 32.35 ± 4.88 32.25 ± 4.8 NS
E wave (msec) 80.60 ± 23.4 78.30 ± 22.5 76.4 ± 21.4 81.32 ± 19.3 77.22 ± 24.5 NS
A wave (msec) 43.87 ± 14.3 50.18 ± 2 55.23 ± 25 45.90 ± 22.3 44.80 ± 25.3 NS
DTc (ms) 176.71 ± 46.8 180.50 ± 23 179.80 ± 34.5 168.80 ± 27.3 184.46 ± 25.6 NS
IVRT (ms) 73.28 ± 13 70.52 ± 15 68.45 ± 12 74.52 ± 15 82.67 ± 16 NS
RV (mm) 25.34 ± 12 24.23 ± 10 23.25 ± 14 25.23 ± 15 26.24 ± 15 NS
EF: ejection fraction; BSA: body surface area; IVS: interventricular septum; PW: posterior wall; LVEDd: left ventricle diastolic diameter; LVESd: left ventricle
systolic diameter; CMI: cardiac mass index; Aoan: aortic annulus; Aosv: aortic dimension at Valsalva sinuses; Aostj: aortic dimension at sinotubular junction;
PAA: dimension of proximal ascending aorta; DTc: deceleration time; IVRT: isovolumic relaxation time; RV: right ventricle.
raphe,” the AP subtype was found in 68%, and the L-A variant
in 37%. The most frequent aortic valve dysfunction was
aortic insufficiency, but also a mild aortic stenosis was found
only in 7/59 (11%) of the whole group investigated, either
“with” or “without” raphe. Some other cardiac associated
congenital conditions such as PFO (5.3%), MVP (5.3%), and
CoA (10.5%)were also found (Figure 4).Only 26%of the BAV
subjects “with raphe” and the 10% of those “without raphe”
underwent surgery for the valve dysfunction or progressive
aortic dilatation.
The main echocardiographic data of the different types
of BAV in athletes are shown in Table 2, with no significant
differences between them at the onset of the study. On
the contrary, significant differences were found in the LV
echocardiography parameters in the group of athletes during
the 5 years of the study (Table 3), with a progressive not
statistically significant enlargement of the LV chamber for all
the BAV groups.
From the Doppler analysis, however, the aortic flow
velocity and the aortic gradient remained normal. At the end
of the 5 years of the study, the LVDD mean values diameters
of every subtype of the BAV morphologies did not show,
however, any significant difference (Figure 5).
Among the sedentary subjects, 41 had a complete 5-year
followup. They showed a progressive not significant decrease
of the values during the observation period for all the LV
chamber parameters (Table 4) (LVEDd of R-L BAV type:
48.80± 7.3mm; R-NC: 49.40± 9.51mm; LA: 46.28± 7.5mm;
AP: 49.68 ± 8.62; L-NC: 50.5 ± 2mm; P: NS for all).
On the contrary, significant differences were found com-
paring theBAVsedentary groupwith the athleteswith respect
to all the echocardiography parameters: PW, IVS, RV, and left
atrium, aortic flow velocity, CMI, LV EDD and LVESD, and
EF (𝑃 < 0.05). (0.001 < 𝑃 < 0.05). All the values were,
however, within the normal range for both groups.
The ex-athletes group was composed of 21 subjects, aged
38.74 ± 12.42, not regularly submitted to a 5-year followup,
in consequence of their sports activity discontinuity. The
echocardiographyc parameters were within the normal range
in this observational period (EF (%) 67.48 ± 4.26; BSA in
(m2): 1.79 ± 4.26; IVS (mm) 9.78 ± 0.3; PW (mm) 10.04 ±
0.67; LVEDd (mm) 55.01 ± 4.52; LVESd (mm) 36.17 ± 2.59
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Table 3: BAV athletes: details of echocardiographic parameters during the 5-year followup.
Year 1 Year 2 Year 3 Year 4 Year 5 P
AGE 19 ± 8.8 20 ± 8.5 21 ± 8.9 22 ± 8.8 23 ± 9.0
IVS (mm) 8.97 ± 1.1 9.30 ± 1 9.43 ± 1.02 9.82 ± 0.7 9.89 ± 0.7 <0.01
PW (mm) 8.57 ± 1.0 9.01 ± 0.9 9.12 ± 0.9 9.53 ± 0.8 9.57 ± 0.8 <0.01
LVEDd (mm) 49.66 ± 4 49.51 ± 5 50.27 ± 4.2 51.47 ± 3.5 52.01 ± 3.9 <0.01
LVESd (mm) 30.61 ± 3.5 30.93 ± 3.8 31.37 ± 2.9 32.66 ± 3.2 32.62 ± 2.9 <0.01
CMI in (g/m2) 103.11 ± 21.0 106.78 ± 23.6 107.79 ± 22.3 115.11 ± 20.8 117.40 ± 20.6 <0.01
EF (%) 67.22 ± 4.1 67 ± 3.4 67 ± 2.5 65.44 ± 3.0 65.59 ± 3.3 0.074
Aortic vel. (m/sec) 1.64 ± 0.3 1.64 ± 0.3 1.67 ± 0.3 1.65 ± 0.3 1.63 ± 0.3 NS
Ao valve gradient (mmHg) 11.44 ± 5.6 11.24 ± 4.6 11.72 ± 5.2 11.38 ± 4.9 11.15 ± 5.1 NS
EF: ejection fraction; IVS: interventricular septum; PW: posterior wall; LVDd: left ventricle diastolic diameter; LVSd: left ventricle systolic diameter; CMI:
cardiac mass index; Ao valve gradient: aortic valve gradient.
Table 4: BAV sedentary: details of echocardiographic parameters during the 5-year followup.
Year 1 Year 2 Year 3 Year 4 Year 5 P
AGE 30 ± 8.1 31 ± 7.5 32 ± 9.2 33 ± 9.5 34 ± 8.3
IVS (mm) 9.63 ± 2.38 9.39 ± 2.69 9.19 ± 2.87 8.87 ± 3.09 8.71 ± 3.15 NS
PW (mm) 9.47 ± 2.36 9.25 ± 2.66 9.07 ± 2.84 8.76 ± 3.06 8.60 ± 3.12 NS
LVEDd (mm) 49.41 ± 12.24 48.08 ± 13.77 47.15 ± 14.70 45.38 ± 15.74 44.58 ± 16.06 NS
LDDS (mm) 28 ± 7.99 30.46 ± 8.90 29.84 ± 9.46 28.67 ± 9.91 28.16 ± 10.11 NS
CMI in (g/m2) 95.44 ± 14.52 97.85 ± 15.42 96.55 ± 16.68 98.67 ± 14.68 95.97 ± 16.85 NS
EF (%) 65.22 ± 4.1 64 ± 3.4 66.54 ± 2.5 65.65 ± 3.0 63.85 ± 3.3 NS
Aortic vel. (m/sec) 1.35 ± 0.4 1.40 ± 0.2 1.37 ± 0.3 1.34 ± 0.3 1.38 ± 0.3 NS
Ao valve gradient (mmHg) 7.29 ± 4.23 7.84 ± 5.12 7.51 ± 4.92 7.18 ± 4.68 7.62 ± 5.03 NS
EF: ejection fraction; IVS: interventricular septum; PW: posterior wall; LVDd: left ventricle diastolic diameter; LVSd: left ventricle systolic diameter; CMI:
cardiac mass index; Ao valve gradient: aortic valve gradient.
Table 5: Echocardiographic features of the ex-athletes with different types of bicuspid aortic valve.
R-L = 11 R-NC = 4 A-P = 7 L-A = 1 P
Age 37.45 ± 12.79 36.85 ± 11.63 38.05 ± 12.75 34.00 ± 0 NS
EF (%) 67 ± 3 66 ± 5 64 ± 7 66 NS
BSA in (m2) 1.78 ± 0.2 1.82 ± 0.2 1.80 ± 0.2 1.80 ± 0 NS
IVS (mm) 10.13 ± 0.97 9.25 ± 0.5 9.64 ± 0.95 9.00 NS
PW (mm) 10.32 ± 0.60 9.50 ± 0.58 10.07 ± 0.60 9.00 NS
LVEDd (mm) 56.27 ± 4.54 56.75 ± 2.22 55.71 ± 5.62 50.00 NS
LVESd (mm) 36.36 ± 3.35 35.75 ± 0.96 36.71 ± 2.82 32.00 NS
CMI in (g/m2) 110.54 ± 20.6 107.64 ± 20.7 109.78 ± 20.3 105 NS
Aoan (mm) 36.45 ± 5.22 37.00 ± 5.16 36.15 ± 6.47 30.00 NS
Aosv (mm) 42.09 ± 5.00 39.75 ± 5.86 39.42 ± 5.89 34.00 NS
Aostj (mm) 33.00 ± 4.7 39.00 ± 8.20 41.57 ± 8.28 29.00 NS
PAA (mm) 32.30 ± 4.92 38.50 ± 5.8 40.14 ± 9.20 26.00 NS
Ewave (msec) 70.36 ± 13.22 54.00 ± 5.41 65.85 ± 16.60 73.00 NS
Awave (msec) 47.90 ± 10.12 37.75 ± 4.5 44.86 ± 12.52 52.00 NS
DTc (ms) 188.45 ± 32.33 200.00 ± 35.60 180.14 ± 23.73 171.00 NS
IVRT (ms) 73.73 ± 14.73 89.50 ± 1.92 77.71 ± 16.02 62.00 NS
RV (mm) 26.12 ± 11.23 25.73 ± 10.25 25.85 ± 13.65 25.00 NS
EF: ejection fraction; BSA: body surface area; IVS: interventricular septum; PW: posterior wall; LVEDd: left ventricle diastolic diameter; LVESd: left ventricle
systolic diameter; CMI: cardiac mass index; Aoan: aortic annulus; Aosv: aortic dimension at Valsalva’s sinuses; Aostj: aortic dimension at sinotubular junction;
PAA: dimension of proximal ascending aorta; DTc: deceleration time; IVRT: isovolumic relaxation time; RV: right ventricle.
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Figure 4: Presence of BAV morphologies and associated cardiac
patterns in sedentaries BAV subjects. LV chamber echoparameters
of athletes and sedentary subjects with different BAVmorphologies.
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Figure 5: LVEDD dimensions of the BAVmorphology after 5 years
of followup. LVVD: left ventricle diastolic diameter; R-L: 50.80 ±
4.3mm; R-NC: 51.04±4.0mm; LA: 48.92±3.5mm; AP: 50.69±3.3;
L-NC: 52.5 ± 2.5mm; P: NS for all.
CMI in (g/m2) 109.75 ± 12.78; Aoan (mm) 36.17 ± 5.42;
Aosv (mm) 40.52 ± 5.40; Aostj (mm) 40.83 ± 6.94; PAA
(mm) 39.39 ± 7.67; E wave (msec) 66.26 ± 14.02; DTc (ms)
77.17 ± 14.61; IVRT (ms) 77.17 ± 14.61; RV (mm) 25.42 ±
2.68). The echocardiographyc feature among the different
BAV subtypes, without any significant difference, is reported
in Table 5.
The different morphologies of BAV represented were
composed in ex-athletes group of 10% of RL BAV aorta; 33%
of AP BAV aorta; 52% of RNC BAV aorta; and 5% of LA BAV
aorta (Figure 6).
As expected, the BAV dimensions measured at 4 dif-
ferent levels show a progressive enlargement during the 5-
year followup period, with a slightly greater increase in
athletes, with no differences between athletes and sedentary
subjects. There was a progressive increase at each measured
aortic level (Aoan: 0.78mm/year; Aosv: 0.61mm/year; Aostj:
Aorta AP
33%
Aorta RNC
52%
Aorta RL
10%
Aorta LA
5%
Aorta AP
Aorta LA
Aorta RNC
Aorta RL
Figure 6: Presence of different BAV morphological patterns in ex-
athletes group. AP: anteroposterior; LA: lateral; RL: right left; RNC:
right noncoronary: LNC: left noncoronary.
0.81mm/year; PAA: 0.98mm/year). These values are com-
parable to those found in previous studies conducted on
nonathletic BAV populations [15].
There was no statistical difference in BAV dimensions
in the three groups studies. The athletes and the sedentary
subject showed significant differences in LV dimensions,
although all the values remained within the normal range.
The ex-athletes showed higher dimension than the other two
groups, but we point out that we do not have longitudinal data
on this group.
5. Discussion
BAV is a common congenital condition, more prevalent in
males. In athletes, competitive sports activity is normally
allowed if the valve dysfunction or the other complications
associated are not severe [9, 16]. Some aspects remain
unsolved, especially in athletes who train regularly. For
example, some changes of the LV have been described [17,
18]. Although they may be considered secondary to the
flow dynamics component and to the entity of the aortic
valve regurgitation, if present, recent studies have shown that
possible structural abnormalities occur at the cellular level,
independent of the hemodynamic impairment of BAV sub-
jects [19, 20]. Following this line of thought, LV dimensions
have been studied especially in athletes, and a progressive
enlargement, however within the normal range, has been
recently demonstrated [9]. Using a dedicated software to
study the deformation parameters of the LV, normal LV
function has been however confirmed. Nevertheless, some
other aspects remain unsolved, especially if a large cohort of
BAV trained athletes with different BAV types is considered.
The diverse BAV types can be associated to a possible more
rapid valve dysfunction, and, therefore, possible impairment
of the LV.
The present longitudinal study, involving a wide group
of BAV subjects with a different prevalence of the BAV
morphological variants, investigates the possible relationship
of the BAV types with morphological and functional aspects
of the LV, thus producing evidence that a given BAV pattern
can play a role in predicting the evolution of the morphology
and function of the LV.
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In the present investigation, the prevalence of the various
types of BAV is in agreement with what was previously
reported. Particularly in athletes, the prevalence of BAV and
the various subtypes are comparable to what was found in the
general population, with a predominance of the variant with
raphe fusion RL. Also, the most common valve dysfunction
pattern associated is valve stenosis, and the prevalence of
cardiovascular comorbidity is otherwise rare. Coarctaction of
the aorta is, in the present population, rare, with a prevalence
of only 1.5%. This is in contrast with the body of available
literature where CoA can be present in up to 40% of BAV
subjects. Probably, this reflects the fact that the present study
was conducted in athletes in whomCoA is a contraindication
to the attainment of fitness to practice competitive sports.
In addition, the follow-up echocardiographic data con-
firm that the LV dimension of BAV athletes tends to be near
the upper limits of normality, although slightly increasing
during the 5-year followup. On the contrary in BAV seden-
taries the LV dimensions remain substantially unchanged if
compared to the athletes. In consideration of the fact that
all the dimensions are within the normal range for both,
the apparent opposite behaviour of the LV chamber of the
two different groups is however reasonably interpreted as a
physiological heart remodelling influenced by regular physi-
cal training. Of note is that the sedentary group also shows a
high prevalence (16%) of surgery from the dysfunction of the
aortic valve.
Being a carrier of a particular morphology of BAV,
according to the results in the present study, cannot predict
future development of pathological valve dysfunction.
The mild enlargement of the left ventricle seems to
be related to the long term sport training, and therefore
compatible with the general feature of athlete’s heart. In
agreement with the current literature, the ascending aorta is
normally involved in progressive, not necessarily pathologi-
cal, enlargement.
In conclusion, the presence of BAV does not therefore
represent an additional risk factor in terms of morphology
and left ventricular function, at least in the presence of mild
valve dysfunction. This aspect seems to be confirmed also in
the presence of those subtypes of valve morphologies well
noted for their high risk of progression to valve dysfunction.
From the results obtained in the large group investigated,
sport activity does not play any additional role in cardiac
morphology and function of trained BAV athletes. Further
studies will be necessary to investigate the possible protective
role of regular sport participation in this population. A large
cohort of subjects, from different types of sports, will be
necessary to verify possible differences among the diverse
sports practised.
6. Limitations and Conclusions
The study has been conducted in a wide population of ath-
letes, but the sedentary group was restricted to relatively few
subjects. A wider population will be needed to clarify the
possible negative impact of specific sports. Additional infor-
mation could be also obtained from the application of
the deformation parameters to better investigate LV perfor-
mance. Particularly in this context, evaluation by the 3D
echo investigation could play a role. In addition, despite the
follow-up study being anyway limited to a 5-year exploration
and therefore restricted, it is reasonable to propose an
echocardiographic exam at least once a year for all the BAV
athletes.
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